Aberdeen Group
QTTB icon

Aberdeen Group’s Q32 Bio QTTB Stock Holding History

Aberdeen Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.5M Buy
+302,500
New +$4.19M ﹤0.01% 782

Other funds holding QTTB

Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Aberdeen Group's QTTB Position: Q3 2026 in Review

Aberdeen Group opened a new position in Q32 Bio (QTTB) in Q3 2026: 302,500 shares worth $2.5M. The stake represents ﹤0.01% of the portfolio and ranks #782 among its holdings.

30 funds tracked by Wall St. Rank hold QTTB as of Q3 2026.

  • Aberdeen Group held 302,500 shares of Q32 Bio worth $2.5M as of Q3 2026.
  • Q32 Bio was a new Aberdeen Group position in Q3 2026.
  • Q32 Bio made up ﹤0.01% of Aberdeen Group's portfolio in Q3 2026, its #782 holding.
  • 30 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2026.

Based on Aberdeen Group's 13F filing for Q3 2026, filed 6 Nov 2026.